News
R&D project spotlight: Enhancing DNA impurity detection in AAV through automation of the PicoGreen assay
CGT Catapult hosts second annual workshop to address digital challenges in adoption of advanced therapies by the NHSRegulatory news - November 2019Press release: Investment in UK cell and gene therapy manufacturing set to continuePress release: Accelerated demand for specialist skills in the UK cell and gene therapy industryCGT Catapult launches commercial readiness advice clinics programme to help cell and gene therapy SMEs and spin-out companies accelerate towards commercialisationRegulatory news - October 2019Regulatory news - September 2019Cell and Gene Therapy Catapult CEO to RetirePress release: Construction completed on expansion phase, doubling capacity of Cell and Gene Therapy Catapult large scale manufacturing centre in StevenageAugust news: Where will we see you this autumn?July news: Developing novel reimbursement practicesJune news: Supporting development of cell and gene therapies
